The classification of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has limitations because the condition includes disorders with similar general clinical features, similar characteristics of lung and renal involvement and a positive ANCA serology. A 40-year-old woman was admitted to our hospital for hemoptysis and dyspnea. She had no history of bronchial asthma. Laboratory examinations revealed hypereosinophilia, positive anti-myeloperoxidase antibodies, hematuria and proteinuria. The patient was ultimately diagnosed with AAV associated with diffuse alveolar hemorrhage, rapidly progressive glomerulonephritis and hypereosinophilia without bronchial asthma. Obtaining a definitive diagnosis of ANCA vasculitis can be very difficult, and the characteristics of this case were not compatible with the findings of typical AVV. We herein report a rare case of AVV.
Introduction
Vasculitides associated with serum positivity for antineutrophil cytoplasmic antibodies (ANCAs) that affect small-tomedium-sized vessels are commonly known as conditions of ANCA-associated vasculitis (AAV). These diseases include granulomatosis with polyangitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangitis (EGPA, also known as Churg-Strauss syndrome). MPA occurs most commonly in middle-aged men and presents with influenza-like prodromal symptoms. The histological findings include small vessel leukocytoclastic vasculitis (LCV) without involvement of medium-sized arteries. The kidneys are affected by focal segmental necrotizing glomerulonephritis with crescent formation. The lungs are involved in 30-40% of patients, often leading to diffuse alveolar hemorrhage (DAH) and a high mortality rate. Conversely, EGPA is characterized by asthma, hypereosinophilia and the presence of transient pulmonary infiltrates. The typical histopathological features of EGPA include eosinophilrich, granulomatous inflammation involving the respiratory tract and necrotizing vasculitis affecting small-to-mediumsized vessels. Rapidly progressive glomerulonephritis (RPGN) and DAH occur less frequently than MPA and GPA. 
ever, her condition did not improve. She had no history of disease and did not use illicit drugs, although she was an ex-smoker and occasionally consumed alcohol. She worked in an office and had no known instances of occupational exposure. A physical examination revealed a body temperature of 37.3 , a blood pressure of 112/68 mmHg, a pulse of 100 beats/min and an oxygen saturation level of 99% while breathing ambient air. Although the patient's nose and sinuses were normal, fine crackles were observed in the left lower lung field, without rhonchi or wheezing in either lung field. Bilateral leg edema was observed. The findings of other general physical and detailed neurologic examinations were normal. The laboratory findings (Table) revealed a leukocyte count of 20,190, comprising 66% eosinophils. The levels of serum creatinine, C-reactive protein, IgE, KL-6 and SP-D were 1.2 mg/dL, 2.2 mg/dL, 1,600 mg/dL, 157 U/mL and 124 ng/mL, respectively. Reactions involving antiglomerular basement membrane antibodies and ANCAs directed toward proteinase 3 (PR3-ANCA) were negative; however, the serum level of positive anti-myeloperoxidase antibodies (MPO-ANCA), which was examined twice, was found to be 1,790 EU and 3,110 EU. A urinalysis revealed hematuria with proteinuria, while cultures of the blood, sputum and urine were sterile. Electrocardiography demonstrated a sinus rhythm with no abnormal findings. The forced expiratory volume in one second (FEV1.0) was normal; however, the vital capacity (VC) and diffusing capacity for carbon monoxide (DLco) were slightly reduced. Chest radiography and CT revealed areas of diffuse ground-glass opacity in the left lung fields (Fig. 1a-c) . To determine the cause of the lung infiltrates, bronchoalveolar lavage (BAL) was performed. The BALF exhibited fresh blood-like fluid containing hemosiderin-laden macrophages and a total cell count of 13.3×10 5 /mL, comprising 86% eosinophils, although no acid-fast bacilli, fungus antigens or Pneumocystis jirovecii were observed. A transbronchial lung biopsy showed capillaritis with eosinophilic inflammation, without vasculitis, malignancy or granuloma formation (Fig. 2) . A few days after admission, the patient's renal function rapidly worsened, and the serum creatinine level increased to 3.1 mg/dL. A subsequent renal biopsy demonstrated fibrocellular crescent formation and glomerular tuft necrosis, consistent with a diagnosis of RPGN (Fig. 3a, b) . Based on these findings, the patient was diagnosed with AAV associated with DAH, RPGN and hypereosinophilia. The difficulty in distinguishing MPA from EGPA in this case suggests that hypereosinophilia may contribute to the development of different disease patterns of MPA.
The patient received intravenous methylprednisolone (m-PSL) at a dose of 1 g/day for three days, followed by oral prednisolone (PSL) at a dose of 40 mg/day. The PSL dose was gradually tapered, and the patient's clinical symptoms resolved. One and a half years after discharge, when the PSL was discontinued, the patient's clinical status worsened and she presented with a productive cough and dyspnea. The level of MPO-ANCA was elevated, and chest CT showed areas of ground-glass opacity in the bilateral upper lobes. The patient was clinically diagnosed with AAV recurrence and subsequently received intravenous m-PSL at a dose of 0.5 g/day for three days, followed by oral PSL at a dose of 60 mg/day. The dose of PSL was gradually tapered, and the patient's clinical symptoms improved.
Discussion
ANCAs were discovered in 1982 by Davies et al.
(1) while studying antinuclear antibodies in the serum samples of patients with segmental necrotizing glomerulonephritis. Subsequently, it was reported that PR3-ANCAs are detected primarily in GPA patients (2), whereas MPO-ANCAs are predominantly detected in patients with MPA and EGPA (3). In 1990, the American College of Rheumatology (ACR) published vasculitis classification criteria (4); however, these criteria did not include MPA or ANCA and comprised any abnormal chest findings, including infiltrates, abnormal urinary sediment and nasal or oral inflammation. Therefore, they were less valuable for differentiating MPA from GPA. In 1994, the Chapel Hill Consensus Conference (CHCC) proposed a definition of vasculitis (5), which included MPA; however, these criteria were not intended to be used for classification. The ACR criteria and CHCC definitions are widely used, although there is no agreement on how they should be applied.
In clinical practice, making a definitive distinction of ANCA vasculitis is occasionally difficult because this condition includes diseases with similar general clinical features, similar characteristics of lung and renal involvement and a positive ANCA serology. MPA is characterized by pauciimmune necrotizing small-vessel vasculitis without granuloma formation with or without the involvement of mediumsized arteries. The clinical spectrum of MPA is similar to that of GPA, although ear, nose, throat and lung involvement is less common, and renal involvement may be the only manifestation. The histological findings include those of small vessel LCV with no involvement of medium-sized arteries. Granuloma formation is absent, and immunofluorescence studies are negative. The kidneys are affected by focal segmental necrotizing glomerulonephritis with crescent formation. Other affected organs include the joints, muscles, gastrointestinal tract, eyes and nervous system. The lungs are involved in 30-40% of patients, often leading to DAH and a high mortality rate. Conversely, EGPA is characterized by hypereosinophilia, asthma and the presence of transient pulmonary infiltrates. Asthma is the cardinal clinical feature of EGPA and is present in more than 95% of patients. Asthmatic symptoms develop in patients with EGPA at a later age and become more severe over time. Radiological abnormalities have been reported in 87% of patients (6), with peripherally distributed parenchymal infiltrates being the most common finding. Other radiological abnormalities include pleural and pericardial effusion, cavitating pulmonary nodules, bronchial wall thickening and thickened interlobular septa. The site of vasculitis is often extrapulmonary, most commonly involving the peripheral nervous system, heart, skin, kidneys and gastrointestinal tract. The typical histopathological features of EGPA include eosinophil-rich granulomatous inflammation involving the respiratory tract and necrotizing vasculitis affecting small-to-medium-sized vessels. Focal and segmental necrotizing glomerulonephritis occurs in 20-47% of cases and is the most common renal abnormality in patients with EGPA (7, 8) . Other renal disease forms occur, including eosinophilic tubular infiltration, granuloma formation and vasculitis. However, renal failure is an uncommon complication of EGPA (9) .
Although several attempts have been made to standardize the classification and diagnostic criteria for small vessel vasculitis (4, 5) , the ACR and CHCC criteria were not intended to be used for classification. Furthermore, histological data may not be available in all patients, particularly when the sample is not representative, salient histological features are overlooked or the clinical condition of the patient precludes obtaining appropriate biopsy samples. In addition, the vasculitis observed in patients with GPA, MPA and EGPA is sometimes pathologically indistinguishable. The concept of surrogate markers of vasculitis was therefore introduced; however, a list of vasculitis markers has not been provided. Watts et al. (10) developed a consensus methodology for classifying AAV. In their algorithm, the EGPA criteria have the highest specificity and are applied first. The author reported that some patients clinically diagnosed with other types of vasculitis may be classified as having EGPA, although the number of affected patients would be very small and the effects would be similar in each hospital.
In this case, our patient had no history of bronchial asthma, and a pulmonary function test revealed a normal FEV1.0. Therefore, the characteristics of this case were not compatible with a diagnosis of EGPA because patients with EGPA usually have long-standing asthma and take systemic corticosteroids. In addition, cases of EGPA presenting with RPGN and/or DAH and biopsy-proven renal lesions fully described in the English literature are rare. Hirohama et al. (11) stated that previously reported EGPA patients presenting with RPGN included 18 men and 12 women with ages ranging from 23 to 86 years. Sugino et al. (12) described only five histologically or endoscopically diagnosed case reports of EGPA complicated by DAH. In particular, rare cases of eosinophilia in patients with GPA (13) or MPA with eosinophilia (14) have been reported. As previously mentioned, obtaining a definitive diagnosis of ANCA vasculitis can occasionally be very difficult. This case was considered to fulfill the criteria for MPA after applying the Watts' classification algorithm. Lyons et al. (15) recently reported that AAV has a genetic component and that there are distinctions between GPA and MPA. The authors suggested that PR3-ANCA-associated vasculitis and MPO-ANCAassociated vasculitis are distinct autoimmune syndromes.
In conclusion, we herein reported an uncommon case of AAV involving DAH, RPGN and hypereosinophilia without asthmatic symptoms.
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